KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Asset Utilization Ratio (2016 - 2025)

Travere Therapeutics (TVTX) has disclosed Asset Utilization Ratio for 12 consecutive years, with 0.86 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 102.13% year-over-year to 0.86, compared with a TTM value of 0.86 through Dec 2025, up 102.13%, and an annual FY2025 reading of 0.82, up 142.69% over the prior year.
  • Asset Utilization Ratio was 0.86 for Q4 2025 at Travere Therapeutics, up from 0.57 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.86 in Q4 2025 and bottomed at 0.1 in Q3 2022.
  • Average Asset Utilization Ratio over 5 years is 0.27, with a median of 0.27 recorded in 2021.
  • Peak annual rise in Asset Utilization Ratio hit 10077.44% in 2022, while the deepest fall reached 137.96% in 2022.
  • Year by year, Asset Utilization Ratio stood at 0.0 in 2021, then soared by 10077.44% to 0.16 in 2022, then decreased by 0.31% to 0.16 in 2023, then surged by 172.1% to 0.42 in 2024, then soared by 102.13% to 0.86 in 2025.
  • Business Quant data shows Asset Utilization Ratio for TVTX at 0.86 in Q4 2025, 0.57 in Q3 2025, and 0.6 in Q2 2025.